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be different. Certain pain qualities may respond more fa-
vourably to specific targets. Knowledge of onset and offset 
times for the targets can guide optimisation of stimulation 
settings. The use of more than one stimulation target may 
be beneficial and should be considered in anaesthesia do-
lorosa patients.  © 2016 The Author(s)
Published by S. Karger AG, Basel 
 Introduction 
 Several deep brain stimulation (DBS) targets have 
been described for the alleviation of resistant central neu-
ropathic pain syndromes, including the periaqueductal 
grey (PAG)  [1] , centromedian-parafascicular (CmPf) nu-
cleus  [2] , sensory thalamus  [3] , subthalamic nucleus  [4] , 
nucleus accumbens  [5] , and anterior cingulate cortex  [6] . 
These activate different neuronal pathways and are likely 
to alter pain perception by distinct mechanisms. There 
have been no studies to date comparing the acute analge-
sic effects of stimulation at the PAG and CmPf targets or 
the consequences of combined site stimulation.
 PAG stimulation is thought (in part) to exert its ac-
tions by a release of endogenous opioid  [7, 8] via a de-
scending modulatory pathway. Low-frequency stimula-
 Key Words 
 De-afferentation pain · Periaqueductal grey · 
Centromedian-parafascicular nucleus · Quantitative 
sensory testing · Depth electrode 
 Abstract 
 Background: Several deep brain stimulation (DBS) targets 
have been explored for the alleviation of trigeminal anaes-
thesia dolorosa. We aimed to characterise the analgesia pro-
duced from the periaqueductal grey (PAG) and centromedi-
an-parafascicular (CmPf) nucleus using a within-subject 
 design.  Method: We report a case series of 3 subjects 
 implanted with PAG and CmPf DBS systems for the treat-
ment of anaesthesia dolorosa. At follow-up, testing of onset 
and offset times, magnitude, and thermal and mechanical 
sensitivity was performed.  Results: The mean pain score of 
the cohort was acutely reduced by 56% (p < 0.05) with PAG 
and 67% (p < 0.01) with CmPf stimulation at mean time in-
tervals of 38 and 16 min, respectively. The onset time was 
12.5 min (p < 0.05) for PAG stimulation and 2.5 min (p < 0.01) 
for CmPf. The offset time was 2.5 min (p < 0.05) for PAG and 
12.5 min (p < 0.01) for CmPf. The two targets were effective 
at different stimulation frequencies and were not antago-
nistic in effect.  Conclusion: The mechanisms by which stim-
ulation at these two targets produces analgesia are likely to 
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tion of PAG results in a sensation of warmth, pleasure, 
satiety, and inebriation  [9] . Another target, CmPf, was 
found serendipitously (after the post-mortem deter-
mined the exact site of depth electrodes) after successful 
treatment of a patient with terminal cancer  [10] . Despite 
the close proximity of CmPf to the PAG, anatomical and 
physiological studies suggest a separate mechanism of an-
algesia  [2] . It is thought to reduce the affective component 
of pain via ascending connections to the anterior cingu-
late nucleus  [11] .
 By studying patients with electrodes implanted into 
these two targets for the successful treatment of trigemi-
nal anaesthesia dolorosa, we attempt to characterise the 
analgesic effect of each target and assess whether a great-
er analgesic effect can be achieved through combined 
stimulation. A meta-analysis of DBS for analgesia found 
a greater mean reduction in pain where electrodes tar-
geted more than one anatomical site  [12] . This group 
only confirmed that multiple targets increased the likeli-
hood of successful stimulation-induced analgesia, but 
the effect of each target alone and in combination was not 
assessed. We hypothesised that PAG and CmPf stimula-
tion would each exhibit distinct characteristics and that 
simultaneous stimulation may be beneficial. Improved 
understanding of timing and response to stimulation in 
these two sites may better inform patient and target se-
lection and assist optimisation of treatment. We report a 
small case series with characterisation of the analgesic 
effects of two stimulation sites both individually and in 
combination.
 Methods 
 Full approval from the NHS ethics committee (Ref. 12/
SW/0255) and the North Bristol NHS Trust research and develop-
ment (Ref. 2875) was obtained for the testing performed. The 
study was registered with the National Institute for Health Re-
search Comprehensive Clinical Research Network (Ref. 13580).
 Operative Method 
 Patients were required to have symptoms and a confirmed 
mechanism of trigeminal nerve damage to be considered for DBS 
(see  table 3 ). Patients with no response to optimal conventional 
treatment under a secondary pain service for 2 years were offered 
DBS as per criteria of the NHS exceptional clinical need panel.
 Planning MRI scans were obtained under general anaesthesia 
using a Leksell frame and localiser unit. Trajectory and co-ordi-
nates for the ventral PAG and CmPf contralateral to the pain were 
derived from individual subject MRIs using NeuroInspire TM soft-
ware (Renishaw, Wotton-under-Edge, UK). Guide tubes were 
placed using stereotaxy, and the position was confirmed with CT 
angiogram. The position of the electrodes (Medtronic 3387) could 
then be modified based on the position of the guide tube. Electrode 
tips protrude 10 mm beyond the guide tube in the same trajectory, 
so contact positions could be confirmed using image software  [13] . 
Each electrode was connected to its own impulse generator (IPG) 
as the targets required different stimulation frequencies. Medtron-
ic Itrel 3 single-channel IPGs were implanted below the clavicle 
bilaterally (with the right-sided IPG always connected to the PAG 
electrode to avoid confusion when programming). Programming 
of IPG was performed 3–5 days after electrode insertion. Repeat 
programing was carried out at routine outpatient follow-up by the 
neurosurgical research fellow.
 Method for Characterising Stimulation Effects 
 All subjects operated on between 2010 and 2012 for anaesthesia 
dolorosa were included in the study. No subjects were excluded. 
All subjects during this period had dual target stimulation. The 
mean follow-up period between DBS insertion and this study was 
19 ± 8 months. Testing for acute analgesic effect, onset/offset of 
effect, and character of analgesic effect using quantitative sensory 
testing (QST) were all carried out over a single day using the pro-
tocol shown in  figure 1 .
 Each patient had both pulse generators switched off prior to 
commencing the testing protocol. This was for 60 min or longer 
until the pain score stabilised (three static readings). Mean timings 
for each part of the protocol are provided in  figure 1 . Each section 
of the testing protocol was continued until the subject’s pain score 
had stabilised, thus the durations on and off stimulation varied 
between subjects and target used. This was to ensure the minimum 
period of discomfort experienced by the patient when stimulation 
was switched off and to reduce the length of the testing protocol 
where no further analgesic benefit was noted in the ‘stimulation 
on’ phase.
 Numeric rating scores (Numeric Rating Scale) for pain were 
assessed at 2.5-min intervals during each section of the protocol. 
A baseline pain score was established prior to the next target be-
ing stimulated. Open questions about the pain character, severi-
ty, and effect of fan-blown air on the face were asked during each 
stage.
 QST was performed at the end of each section. The subject 
clicked a button when they could sense a change in temperature or 
discomfort from the thermode placed on their affected cheek (sur-
face area of 9 cm 2 ). The subjects were asked to close their eyes dur-
ing all testing. A thermal sensory analyser (TSA 2001-II; MEDOC, 
Israel) was used to determine the cold detection threshold, warm 
detection threshold, cold pain threshold, and hot pain threshold. 
The thermode temperature was increased or decreased from 32  °  C 
at 1  °  C per second for temperature detection and 1.5  °  C per second 
for temperature pain threshold using the ‘limits method’  [14] . The 
threshold was determined from the mean of four trials for cold and 
warm sensory detection  [15] and three trials for hot and cold pain 
thresholds. Mechanical hypersensitivity was assessed using von 
Frey hairs, and dynamic allodynia was determined by brushing the 
skin with a cotton wool bud.
 Statistical analysis was performed using PRISM software (V6 
Graphpad, La Jolla, Calif., USA). A repeated-measures one-way 
ANOVA test was used to assess the significance of pain scores over 
time and between different stimulation combinations. Sidak’s post 
hoc multiple comparison test was used with correction for multi-
ple comparisons. Changes in sensory and pain temperature thresh-
olds from PAG stimulation were assessed using paired t tests.
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 Results 
 Patient Characteristics 
 The mean age of the cohort was 44.3 ± 6.7 years. Sur-
gery was deemed highly successful in all subjects whose 
mean pain reduction was 67.3 ± 6.7% at the time of re-
cruitment for this study. This was after a mean duration 
of 18.7 ± 8.0 months of DBS. The range of stimulation 
frequencies producing optimal analgesia was 5–10 Hz for 
the PAG electrode and 70–150 Hz for the CmPf electrode 
( table 1 ). A comparison of analgesic medication prior to 
implantation with that being used at the time of this study 
has been provided ( table 2 ).
 Quantifying Stimulation-Derived Analgesia 
 The pain score changed significantly with each stimu-
lation combination (p < 0.05, F score 8.97, 5 d.f.). The 
mean pain score of the cohort (Numeric Rating Scale) was 
acutely reduced from 5.5 ± 1.3 to 2.4 ± 0.9 (56% reduc-
tion, p < 0.05) for PAG stimulation and from 6.7 ± 0.7 to 
2.2 ± 0.7 (67% reduction, p < 0.01) for CmPf stimulation 
( fig. 2 ). Dual target stimulation produced a mean reduc-
tion in pain score from 6.2 ± 0.2 to 1.7 ± 0.7 (73% reduc-
tion, p < 0.01). There was no significant difference be-
tween the degrees of analgesia seen with individual or 
combined stimulation targets in our small sample. The 
change in pain score was recorded over a testing period 
 Table 1.  Characteristics, DBS duration, analgesic response, and stimulation settings for subjects operated on between 2010 and 2012 for 
anaesthesia dolorosa
Subject
ID
Sex Age,
years
Duration 
of DBS, 
months
Pain score 
before 
surgery
Pain score
at 1 week
(% reduction)
Pain at most
recent clinic
visit (% reduction)
PAG settings CmPf settings
1 F 50 15 9 2 (78) 2 (78) 1 V × 150 μs at 10 Hz
(lead 2–, 3–, case+)
2.5 V × 90 μs at 120 Hz
(lead 3–, case +)
2 M 31 7 10 3 (70) 4.5 (55) 4.3 V × 90 μs at 10 Hz
(lead 0–, 1–, 2, 3, case+)
2 V × 60 μs at 150 Hz
(lead 2+, 3–)
3 F 52 34 8.5 0 (100) 3 (69) 5 V × 120 μs at 5 Hz
(lead 0–, 3+)
2.5 V × 90 μs at 70 Hz
(lead 0–, 1+)
 Pain as a function of Numeric Rating Scale pain score, with percentage relief provided in brackets.
PAG off,
CmPf off
93±33
PAG on,
CmPf off
38±14
PAG off,
CmPf off
25±3
CmPf on,
PAG off
16±4
CmPf off,
PAG off
19±5
CmPf on,
PAG on
27±17 min
Pain scores (0–10) at 2.5-minute intervals until successive scores were unchanged
QST (CPT/HPT/CDT/WDT/MH/DA)
and qualitative descriptors of pain character recorded at the end of each period
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 Fig. 1. The stimulation testing protocol performed in the clinic af-
ter a mean follow-up period of 19 months. CPT = Cold pain 
threshold; HPT = hot pain threshold, CDT = cold detection thresh-
old; WDT = warm detection threshold; MH = mechanical hyper-
sensitivity; DA = dynamic allodynia. The mean time period to 
achieve stabilisation of pain scores is provided along with the stan-
dard error (SE) to the nearest minute above each section. Stimula-
tion off times had to be individualised to minimise patient discom-
fort as per ethical approval. 
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of 38 ± 14, 16 ± 4, and 27 ± 17 min for PAG alone, CmPf 
alone, and both PAG and CmPf stimulation, respectively 
( fig. 1 ,  3 ).
 Onset Time.  The time taken to generate a significant 
analgesic response to stimulation was found at 12.5 min 
(p < 0.01) for PAG and 2.5 min for CmPf (p < 0.001; 
 fig. 3 a, b).
 Washout. When stimulation was withdrawn (after 
having been on for a minimum of 40 min), a significant 
reversal of the analgesic effect was apparent at 2.5 min 
(p < 0.01) for PAG stimulation and at 12.5 min (p < 0.01) 
for CmPf stimulation.
 Characterising Analgesic Effect through QST. All 3 
subjects demonstrated improvements in their cold pain 
threshold with PAG stimulation from 27.7 ± 0.4 to 23.3 
± 2.0   °   C, but the change was not significant (two-tailed 
paired t test, p = 0.2;  fig. 4 ). No trend was seen in cold 
pain threshold with CmPf stimulation. Stimulation re-
sulted in no change to other QST temperature thresholds 
(warm detection threshold, hot pain threshold, cold de-
tection threshold), nor was there a change in mechanical 
hypersensitivity as assayed with von Frey hairs. Howev-
er, dynamic allodynia, as tested with a brush from a cot-
ton bud, was attenuated by both PAG and CmPf stimula-
0
2
4
6
8
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Pa
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 (0
–1
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mu
lat
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f in
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l
PA
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on
 Cm
Pf 
off
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G 
off
 Cm
Pf 
off
Pf 
on
 PA
G 
off
PA
G 
off
 Cm
Pf 
off
PA
G 
on
 Cm
Pf 
on
* ** **
 Table 2.  Medication prior to DBS implantation compared to 6-week medication diary performed at the time of 
this study
Subject Prior to DBS implantation At time of study
1 Paracetamol 1 g p.r.n. Paracetamol 1 g p.r.n.
Pregabalin 200 mg t.d.s. Pregabalin 200 mg b.d.
Venlafaxine M/R 150 mg o.d. Venlafaxine M/R 150 mg o.d.
Diazepam 4 mg p.r.n. Diazepam 4 mg p.r.n.
Tramadol M/R 150 mg nocte
Carbamazepine 100 mg 6× per day
(previously: Gabapentin)
2 Gabapentin 700 mg t.d.s. No medication
Buprenorphine 10 μg/h
Lignocaine patch 5%
Tramadol 100 mg p.r.n.
Mirtazapine 30 mg b.d.
Nortriptyline 75 mg o.d.
(previously: Carbamazepine, Oxycarbamazepine, 
Lamotrigine, Oxycodone, intravenous/nasal lidocaine)
3 Morphine (MST) 30 mg b.d. Morphine (MST) 30 mg o.d.
Amitriptyline 150 mg nocte Amitriptyline 150 mg nocte
Pregabalin 300 b.d. Pregabalin 150 mg b.d.
Carbamazepine 200 mg 5× per day
(previously: Fluoxetine, Venlafaxine, Sodium Valproate 
and Gabapentin)
 Fig. 2. Mean pain score reduction for different DBS sites.  *  p < 0.05, 
 * *  p < 0.01; SE displayed using error bars. 
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tion. This approached significance (p = 0.058, F = 4.4, 
d.f. = 3). The post hoc test revealed that when PAG and 
CmPf stimulation were used in combination there was a 
significant change in allodynia score (p = 0.04, d.f. = 6; 
 fig. 4 ).
 Qualitative Characterisation of Analgesic Effect. Qual-
itative changes in pain were recorded in response to stim-
ulation at both targets ( table 3 ). PAG stimulation attenu-
ated spasm frequency and provided a sensation of warmth 
bilaterally. CmPf appeared to reduce the unpleasantness 
of pain while providing a distracting paraesthesia over the 
painful area. A summary of all observations is provided 
( table 4 ).
 Discussion 
 DBS Target Choice 
 DBS has been employed for chronic pain with varying 
degrees of success  [16] . This may reflect the challenge of 
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 Fig. 3. Timing of onset and offset of analgesia in response to DBS 
at the PAG and CmPf nucleus in anaesthesia dolorosa subjects. 
 a Mean pain score against time after PAG stimulation is switched 
on (p = 0.03, F = 3.1, d.f. = 7).  b Mean pain score against time after 
CmPf stimulation is switched on (p = 0.0002, F = 21.9, d.f. = 4). 
 c Mean pain score in response to PAG stimulation being stopped 
(p = 0.01, F = 5.5, d.f. = 5).  d Mean pain score in response to CmPf 
stimulation being stopped. (p = 0.01, F = 5.7, d.f. = 5). SE bars are 
provided at each mean pain score.  *  p < 0.05,  * *  p < 0.01,  * * *  p < 
0.005, referring to sub-analysis using Sidak’s test. 
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target selection in a complex patient population. How-
ever, those who do benefit report substantial relief of pre-
viously intractable pain  [12] . It has been postulated that 
PAG stimulation is better suited to nociceptive pain, 
whereas sensory thalamic and potentially CmPf targets 
are more effective in neuropathic pain  [1, 2] . Our data 
also point to different mechanisms for the analgesia pro-
duced by PAG and CmPf stimulation. Historically, only 
subjects responding to a trial of systemic morphine fol-
lowed by naloxone reversal were offered PAG stimulation 
 [1] , but this selection process has not been widely adopt-
ed. We propose that characterisation of patients’ pain ex-
perience may help to direct anti-nociceptive target selec-
tion, improving patient outcomes.
 Timing 
 The onset and offset times and analgesic characteris-
tics for stimulation-derived analgesia have not been ex-
amined in the follow-up setting in humans before. Intra-
operatively ‘a pleasant warmth’ has been described after 
15–20 min of PAG stimulation  [1] . PAG stimulation off-
set times are as short as 5 min in rodents  [7] and may be 
as long as 24 h in man  [17] . Even less has been document-
ed concerning CmPf stimulation onset and offset times in 
humans. We found a reliable time frame for the onset and 
offset of acute effects in our cohort of 3 anaesthesia dolo-
rosa subjects (which was replicated in our phantom limb 
pain patients; unpubl. data). Our results should inform 
clinicians performing intra-operative trials of micro-
stimulation and those involved in DBS programming.
 Quantitative Sensory Testing 
 Several studies suggest that temperature-related or 
burning pain  [18, 19] responds well to PAG stimulation. 
In support of this we have demonstrated that PAG stimu-
lation objectively alters the cold pain threshold using 
QST. Considering the large changes in the overall pain 
score it is surprising that changes to thermal and mechan-
ical static pain are so small. This does not support a prin-
cipal mechanism of anti-nociception via a descending ac-
tion on nociceptive pathways in general, and other mech-
anisms of action for analgesia must be inferred.
 Allodynia Attenuation 
 Attenuated sensitivity to a cotton bud brush, as a mea-
sure of tactile allodynia, was demonstrated with both 
PAG and CmPf stimulation. This reduction in hyperalge-
sia in the presence of normal static mechanical sensation 
has been described previously in response to PAG stimu-
lation for post-stroke pain  [18] .
 Qualitative Aspects of Pain Character 
 CmPf stimulation appears to modify the affective and 
motivational components of pain  [2] . This was noted by 
all of our subjects who reported the pain to be less un-
pleasant. The CmPf is connected directly to the anterior 
cingulate cortex  [19] and indirectly to the amygdala via 
the medial dorsal nucleus of the thalamus, which may ex-
plain its ability to influence these emotional aspects of 
pain.
 Different Mechanisms 
 The different frequencies, analgesic qualities, and con-
nectivity seen in PAG and CmPf stimulation strengthen 
our hypothesis of differing mechanisms and support the 
a
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*
 Fig. 4. Positive QST findings (timing between stimulation combi-
nations as per figure I).  a Change in cold pain threshold after a 
mean of 38 minutes (±14) of PAG stimulation. Two-tailed paired 
t test (p = 0.2).  b Change in dynamic allodynia score (Numeric 
Rating Scale) for each stimulation combination.  *  p < 0.05. 
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use of these targets in combination. Our results suggest 
that the analgesic effects of PAG and CmPf stimulation 
may be useful in combination, but we were unable to 
demonstrate any synergy in their effects on the overall 
pain score. However, all patients preferred using both 
pulse generators in combination as each target provided 
useful qualitatively distinct aspects of relief to their pain. 
Bittar et al.  [12] have described increased success of sur-
gery where two or more targets were implanted. This was 
thought to be due to the complexity of selecting the cor-
rect target for the specific pain type. Our results take this 
one step further: by using targets which act through dif-
ferent mechanisms we may be able to offer patients a 
more comprehensive analgesic response to their pain 
syndrome with no loss of efficacy at either target.
 Conclusion 
 The mechanisms by which the stimulation targets 
PAG and CmPf achieve analgesia are likely to be differ-
ent. Certain pain qualities may favour specific targets. 
 Table 4.  Summary comparison of the characteristics of stimulation targets individually and in combination
Target Frequency,
Hz
Approximate time
for analgesic effect
to stabilise with
stimulation, min
Approximate time for
analgesia reversal to
stabilise (washout) with 
stimulation arrest, min
Anal-
gesic
effect
Character of analgesia Increases
threshold
to cold pain
Attenuates
dynamic
allodynia
PAG 5 – 10 15 7.5 yes Warmth; feeling
of contentment
yes yes
CmPf 70 – 150 7.5 12.5 yes Pain better tolerated; 
paraesthesia provides 
distractive paraesthesia
no yes
Combined yes both yes yes
 Table 3.  Qualitative data showing the effect of stimulation on the character of pain
Sub-
ject
Mechanism of injury Pain quality PAG effect CmPf effect
1 Diagnostic glycerol injection into the 
trigeminal nerve ganglion performed with no 
relief of symptoms and complicated by a loss 
of sensation to V1, V2, and V3 dermatomes
Constant burning pain; reduced sensation 
and paraesthesia over V1, V2, and V3 
dermatomes; pain increased by noise
Skin feels less tight; 
reduction in pins and 
needles; can tolerate 
wind on face
Face pain duller; cheek 
feels the same pain but 
perceived as less 
unpleasant
2 Assaulted in 2005, sustaining multiple facial 
stab wounds from a screwdriver; a fracture 
through his left zygoma resulted in a unilateral 
loss of facial sensation and taste; an MRI 
demonstrated no vascular compression of the 
trigeminal nerve ganglion, only a cyst-like 
lesion (which may have been a neuroma) in 
the left maxillary sinus, which was surgically 
excised; subsequent to this operation his facial 
pain worsened acutely
Continuous throbbing, aching pain like 
something very hot or cold is running 
across the cheek; paroxysmal shooting 
pains within the maxillary branch (V2) of 
the trigeminal nerve; shooting pain 
triggered by cold air, laughing, talking, 
and eating; severe allodynia over V2 
dermatome
Reduction in frequency 
of shooting pains and 
relief from aching pain
Skin feels numb; less 
sensitive to wind on face; 
dizzy for 30 s when first 
switched on
3 Diagnosed with trigeminal neuralgia; MRI 
confirmed vascular compression, and 
microvascular decompression alleviated her 
symptoms for 6 weeks before the pain 
returned; a partial sensory rhizotomy was 
performed which qualitatively altered the 
characteristics of her pain in keeping with the 
development of anaesthesia dolorosa
Tingling in cheek present 90% of time; 
burning and shooting pains triggered by 
radiant heat or cold air, talking, and hot 
drinks; increased sensitivity with noise
Slight warm sensation 
across face; reduced 
sensitivity to cold air
Patient described having 
a ‘comfortable’ pain: ‘it is 
still there but I can 
tolerate it and it doesn’t 
seem to affect me so 
much’; tingling over face; 
reduced allodynia to 
wind/touch
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PAG stimulation may be effective against cold pain, 
whereas CmPf stimulation may alter the affective and 
motivational components of pain, while providing a dis-
tractive paraesthesia. Improved understanding of timing 
and response to stimulation in these two anatomical lo-
cations may better inform patient selection and promote 
optimal treatment and programming. Pain characteris-
tics in this population are multi-faceted. The effect of us-
ing PAG and CmPf targets simultaneously does not re-
sult in antagonism and may offer a broader analgesic re-
sponse to complex pain symptomatology. The use of 
more than one stimulation target should be considered 
for patients with trigeminal anaesthesia dolorosa under-
going DBS.
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